AccuStem Sciences Limited (ACMSY)
OTC
Healthcare
Medical - Diagnostics & Research
$0.13
▼ -7.14%
Market Cap
$0
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.00
52-Wk Range
0.12-0.13
CEO
—
Country
GB
Currency
USD
AccuStem Sciences Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in London, GB. The stock last traded at $0.13, down 7.14% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of -1.08, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-1.08
Price / Sales
0.00
Price / Book
-0.54
EV / EBITDA
0.01
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2021-07-21
Headquarters
London, GB
About AccuStem Sciences Limited
AccuStem Sciences Limited, founded in 2020 and headquartered in London, United Kingdom, focuses on providing diagnostic assays that utilize genomic signatures. These tests are developed to forecast the probability of both short-term and long-term relapse of ER+/HER2 breast cancer in individuals with an early-stage diagnosis.
More research on ACMSY
Open full interactive analysis & DCF →